Nuwellis (NASDAQ:NUWE) Posts Earnings Results, Misses Estimates By $0.22 EPS

Nuwellis (NASDAQ:NUWE) announced its quarterly earnings results on Tuesday. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.22), Zacks reports. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%.

Nuwellis Stock Down 9.9 %

NASDAQ:NUWE traded down $0.13 during mid-day trading on Tuesday, hitting $1.14. 98,475 shares of the stock traded hands, compared to its average volume of 994,468. The business’s 50-day moving average price is $1.21 and its 200 day moving average price is $1.34. The company has a market cap of $4.96 million, a PE ratio of -0.01 and a beta of 0.36. Nuwellis has a 12-month low of $0.92 and a 12-month high of $17.85.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.